@drjohnm @UofTNeuroSurge https://t.co/eZWKWWCqMt when a community has buy in that a technology works, no one will enroll in clinical trials.IMS-III showed us how cherry picking enrollment without narrowly defined inclusion criteria can lead to negative …
RT @WorldStrokeEd: An example of problematic patient selection is illustrated in #IMS III trial 👉Did not require confirmation of the presen…
RT @WorldStrokeEd: An example of problematic patient selection is illustrated in #IMS III trial 👉Did not require confirmation of the presen…
An example of problematic patient selection is illustrated in #IMS III trial 👉Did not require confirmation of the presence of a vascular occlusion before randomization 👉~ 1/4 of pt did not receive EVT 👉Half of EVT pt were treated with IA tPA only https…